Therefore, the present study was aimed to investigate the serum levels of IL-17A in NMSC patients.<h4>Methods</h4>This cross-sectional study was performed on 60 patients with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) as well as 57 age-sex matched healthy individuals as control group. The gene discussed is IL17A; the disease is skin basal cell carcinoma.